- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06835556
편집증의 변동성 (VIP)
박해 망상에서 신념 업데이트의 역할을 테스트합니다
The goal of this clinical trial is to learn whether learning and belief updating change in response to the treatment of persecutory delusions, in individuals with schizophrenia-spectrum disorders.
The main questions are:
- do prior expectations about environmental volatility reduce following effective psychotherapeutic treatment of delusions?
- does corresponding brain activity related to volatility change with effective treatment of delusions?
Participants will:
- engage in CBTp or TAU + phone check-ins for 16 weeks
- complete assessments at 4 timepoints over the course of 6 months
- complete an MRI when possible
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Julia Sheffield, PhD
- 전화번호: 615-343-3839
- 이메일: julia.sheffield@vumc.org
연구 장소
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37212
- 모병
- Vanderbilt University Medical Center
-
연락하다:
- Julia Sheffield, PhD
- 전화번호: 615-343-3839
- 이메일: julia.sheffield@vumc.org
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Men and women age 18 - 65.
- Communicative in English.
- Premorbid IQ >79 (WTAR)
- Provide voluntary, written informed consent.
- Stable medication regimen over at least the past two weeks, including the use of either an oral or intramuscular administration of an antipsychotic medication.
- Diagnosis of a non-affective psychotic disorder (e.g. schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder)
- A persecutory delusion scoring at least a 3 on the conviction scale of the Psychotic Symptoms Rating Scale (PSYRATS) that had persisted for at least two months and that was not considered the direct result of substance use.
Exclusion Criteria:
- Serious medical or neurological illness known to interfere with cognitive functioning (uncontrolled/unstable diabetes, uncontrolled hypothyroidism, Cushing's disease, Lupus, any demyelinating disease such as Multiple Sclerosis, HIV infection, CNS infection, unstable heart disease, active hepatitis, other significant endocrine condition, any cancer involving the CNS/brain, any uncorrected vision problems, tardive dyskinesia).
- History of severe head trauma with loss of consciousness >30 minutes.
- Primary diagnosis of alcohol or substance use disorder or personality disorder
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 기초 과학
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: CBTp
Weekly individual psychotherapy targeting specific maintenance factors of paranoia (worry, anomalous experiences, self-confidence, and safety behaviors), tailored to the participant's experience |
Individuals will be assessed for which psychological factors are maintaining paranoia in their daily lives. They will collaboratively identify one maintenance factor to focus on (e.g. worry, anomalous experience, self-confidence, PTSD) for 8 weeks of individual therapy. Then, all participants will transition to 8 weeks of individual therapy focused on dropping safety behaviors and re-engaging in everyday life. |
|
활성 비교기: TAU + Phone Check-In
Participants will continue with their regular care (treatment as usual (TAU)) without interference from the study team. In addition to TAU, a study therapist will call them weekly to review what treatment the participants have engaged in. Phone calls will last approximately 5-10 minutes |
Individuals will continue treatment as usual (TAU). In addition they will have contact with a study therapist weekly via phone to provide information on what treatment they received. Phone check-ins will last approximately 5-10 minutes. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in prior expectations of volatility (mu3)
기간: Baseline to 16 weeks
|
Reversal learning data will be collected from a 3-option probabilistic reversal learning task. This data will be analyzed using a computational model that estimates the prior expectations of environmental volatility. That parameter, in many models, is Mu3. |
Baseline to 16 weeks
|
|
Change in unexpected uncertainty (kappa)
기간: Baseline to 16 weeks
|
Reversal learning data will be collected from a 3-option probabilistic reversal learning task. This data will be analyzed using a computational model that estimates the unexpected uncertainty, sometimes also referred to as sensitivity to volatility. |
Baseline to 16 weeks
|
|
Change in psychotic Symptom Rating Scale (PSYRATS)- Belief Subscale Total
기간: Baseline to 16 weeks
|
The PSYRATS is a interview-assisted assessment measuring the severity of a delusional belief. Total scores range from 0-24 with high scores indicating more severe delusion; 6 questions, 0-4 scale for each item |
Baseline to 16 weeks
|
|
Change in PANSS Positive Symptoms - Total
기간: Baseline to 16 weeks
|
The PANSS is a 30-item clinician-rated instrument for assessing schizophrenia symptoms. It consists of 3 subscales: positive subscale (7 items), negative subscale (7 items), and general psychopathology subscale (16 items). For each item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score for each participant was sum of the rating assigned to each of the 30 PANSS items, and ranged from 30 to 210 with a higher score indicating greater severity of symptoms. The positive symptom total score is the sum of the Positive Symptom items |
Baseline to 16 weeks
|
|
BOLD activation change during PRL task, pre/post treatment - prefrontal cortex
기간: Baseline to 16 weeks
|
functional MRI will be used to collect BOLD activation data during the PRL reversal learning task. The investigators expect changes in activation following treatment, particularly in the CBTp group |
Baseline to 16 weeks
|
|
BOLD activation change pre/post treatment - striatum
기간: Baseline to 16 weeks
|
functional MRI will be used to collect BOLD activation data during the PRL reversal learning task. The investigators expect changes in activation following treatment, particularly in the CBTp group |
Baseline to 16 weeks
|
|
BOLD activation change during PRL task, pre/post treatment - locus coeruleus
기간: Baseline to 16 weeks
|
functional MRI will be used to collect BOLD activation data during the PRL reversal learning task. The investigators expect changes in activation following treatment, particularly in the CBTp group |
Baseline to 16 weeks
|
|
Task-based functional connectivity changes during PRL task, pre/post treatment - prefrontal cortex to striatum
기간: Baseline to 16 weeks
|
Functional connectivity during the PRL task will be quantified between the dlPFC and striatum |
Baseline to 16 weeks
|
|
Volatility Expectations - During Stable3 Task
기간: Change from baseline
|
Change from baseline
|
|
|
Scale of Unpredictability Beliefs
기간: Change from baseline
|
Change from baseline
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
PRL 작업 중에 대담한 활성화 변경, 사전/후 치료 - 전체 뇌 분석
기간: 기준선에서 16 주
|
기준선에서 16 주
|
|
|
Change in PANSS P1 Item
기간: Baseline to 16 weeks
|
The PANSS is a 30-item clinician-rated instrument for assessing schizophrenia symptoms. It consists of 3 subscales: positive subscale (7 items), negative subscale (7 items), and general psychopathology subscale (16 items). For each item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score for each participant was sum of the rating assigned to each of the 30 PANSS items, and ranged from 30 to 210 with a higher score indicating greater severity of symptoms. P1 is the first item on the scale, representing delusion severity |
Baseline to 16 weeks
|
|
Change in PANSS P6 Item
기간: Baseline to 16 weeks
|
The PANSS is a 30-item clinician-rated instrument for assessing schizophrenia symptoms. It consists of 3 subscales: positive subscale (7 items), negative subscale (7 items), and general psychopathology subscale (16 items). For each item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score for each participant was sum of the rating assigned to each of the 30 PANSS items, and ranged from 30 to 210 with a higher score indicating greater severity of symptoms. P6 is the item on the scale assessing severity of paranoia/suspiciousness |
Baseline to 16 weeks
|
|
Change in meta-volatility learning rate (omega3)
기간: Baseline to 16 weeks
|
Reversal learning data will be collected from a 3-option probabilistic reversal learning task. This data will be analyzed using a computational model that estimates the meta-volatility. |
Baseline to 16 weeks
|
|
PSYRATS Hallucinations
기간: Change from baseline
|
Change from baseline
|
|
|
Kamin Blocking
기간: Change from baseline
|
Change from baseline
|
|
|
Social Hallucinations - Chasing
기간: Change from baseline
|
Change from baseline
|
|
|
Minnesota Trust Game
기간: Change from baseline
|
Change from baseline
|
|
|
r-GPTS
기간: Change from baseline
|
Change from baseline
|
|
|
DWQ
기간: Change from baseline
|
Change from baseline
|
|
|
BDI-II
기간: Change from baseline
|
Change from baseline
|
|
|
O-AS
기간: Change from baseline
|
Change from baseline
|
|
|
Positive Thoughts Scale
기간: Change from baseline
|
Change from baseline
|
|
|
Guilt and Shame Experiences Scale
기간: Change from baseline
|
Change from baseline
|
|
|
O-CDQ
기간: Change from baseline
|
Change from baseline
|
|
|
Insomnia Severity Index
기간: Change from baseline
|
Change from baseline
|
|
|
PCL-5
기간: Change from baseline
|
Change from baseline
|
|
|
CEFSA
기간: Change from baseline
|
Change from baseline
|
|
|
DERS-16
기간: Change from baseline
|
Change from baseline
|
|
|
Intolerance of Uncertainty
기간: Change from baseline
|
Change from baseline
|
|
|
LSAS
기간: Change from baseline
|
Change from baseline
|
|
|
LSNS-6
기간: Change from baseline
|
Change from baseline
|
|
|
CHOICE
기간: Change from baseline
|
Change from baseline
|
|
|
WEMWBS
기간: Change from baseline
|
Change from baseline
|
|
|
MCQ-36
기간: Change from baseline
|
Change from baseline
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 240788
- R01MH137024 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .